Flat-style illustration of an automated laser drilling line for osmotic tablets, with a conveyor belt, laser head, vision camera, and reject chute removing off-spec tablets into a bin.

Quality Control for Laser-Drilled Osmotic Tablets: SPC on Pore Size, Position, and Automatic Rejection

Introduction: For osmotic controlled-release tablets, the “whether, how big, and where” of each micro-orifice directly defines the release profile. If pore presence, diameter, and position are not tightly controlled, it becomes impossible to lock in a stable dissolution curve or to pass bioequivalence and consistency evaluations.

To move from lab-scale prototypes to GMP commercial production, manufacturers need a closed loop that connects inspection → traceability → automatic rejection instead of relying on sporadic manual checks.

Common Failure Modes in Laser-Drilled Osmotic Tablets

  • Wrong-side drilling. The release orifice is drilled on the non-drug layer side, or on the wrong face of the tablet, causing distorted or completely invalid release curves.
  • Pore size and position drift. Within-batch and between-batch variability in pore diameter and location makes it difficult to maintain a stable, registrable process window.
  • Missed defects and false rejects. Manual sampling or unstable lighting conditions lead to under-detection of real defects and unnecessary rejection of good tablets.

Using SPC and Online Recognition for Pore Control

To make pore quality measurable and controllable, HUANGHAI recommends combining machine vision with statistical process control (SPC):

  • Turn pore quality into SPC metrics. Use the mean pore diameter, standard deviation, and off-target rate as core indicators. Plot control charts for pore size and position to monitor drift over time.
  • Online recognition and traceability. A stable light source plus a dedicated machine vision system allow the line to record who, when, where, and what result for each batch and each tablet population.
  • Automatic rejection. Link the classification result of the vision system directly to the rejection mechanism, so non-conforming tablets are automatically removed with minimal operator intervention.

HUANGHAI’s Practice: Closed-Loop Control with Olando K3-2

HUANGHAI’s Olando K3-2 Pharmaceutical Laser Drilling System is designed around this closed-loop concept:

  • Integrated vision inspection. The system combines precision laser drilling with machine vision so that pore presence, diameter, and position are checked for every tablet against predefined criteria.
  • Audit trail and exception handling. Inspection results, alarms, and rejection events are stored with timestamps and operator IDs, supporting audit trails and regulatory review.
  • Automatic rejection of defective tablets. Detected defects are linked to the physical rejection mechanism, reducing manual handling and lowering the risk of defective tablets reaching downstream processes.
  • Registration-ready documentation. From production logs to batch record templates, HUANGHAI provides documentation support to strengthen registration dossiers and on-site inspections.
  • Integration with upstream and downstream steps. The laser drilling system can be linked with upstream compression/coating and downstream testing and packaging, forming a traceable quality loop for each batch of osmotic tablets.

Conclusion: From “Able to Drill” to “Able to Audit”

For osmotic tablets, it is not enough for a laser drilling line to simply “drill holes.” Manufacturers must use statistical control to stabilize pore diameter and position, deploy machine vision plus automatic rejection to minimize human error, and maintain audit-ready electronic records.

By combining SPC, online vision inspection, and integrated rejection on systems like HUANGHAI’s Olando K3-2, tablet producers can upgrade their laser drilling process from merely being able to produce to being fully auditable, supporting both daily operations and regulatory submissions.

Related Products and Resources

Back to blog

Contact us